All News

Priority review status will allow for expedited development of zongertinib, putting it on the path toward approval as the first in a new class of drugs for mutated NSCLC.

The 75 minutes of infusion time typically required is costly and difficult for patients.

T-DXd has a boxed warning for interstitial lung disease and pneumonitis.

PfSPZ-LARC2 is a genetically engineered malaria vaccine that marks a significant step forward in combating malaria around the world.

Educating patients about lifestyle modifications is a critical part of preventing cerebrovascular events.

Using new treatment advances, traditional medications, genetic profiles, immunotherapies, and individualized plans enables providers to improve outcomes for patients with TPBC.

The test offers an accurate, fast, low-cost, and noninvasive tool for early diagnosis of pancreatic ductal adenocarcinoma.

Pharmacists play a vital role in supporting patients with endometriosis through guidance on treatment options and managing side effects.

Embedding a pharmacist in the dermatology clinic improved clinical and financial outcomes.

These findings may lead to new therapies to help reduce the risk of heart disease in women who are at risk.

Treatment selection includes patient factors, cost, adverse effects, and drug interactions.

QPL use in the pharmacy setting may enhance patient engagement while allowing pharmacists to showcase their medication-related expertise.

Identifying and managing IVIG-related side effects early on in treatment can improve efficacy and safety for patients with CIDP.

Coinfection with RSV and hRV is linked to a higher prevalence of lower respiratory tract infections, according to new data.

Many patients may struggle to understand the complex immunization schedules compiled by the CDC.

Research suggests H5N1 may be spreading undetected among humans, particularly in veterinarians with frequent animal exposure.

Although larsucosterol did not show statistical significance, it showed clinically meaningful trends in 90-day mortality in patients with severe alcohol-associated hepatitis.

Prescribing and dosing appropriate treatments for patients with sickle cell disease while managing episodes of acute pain are some of the integral roles of pharmacists.

All stakeholders should work together to determine and address drug shortages.

Phil Vigeant shares insights on the health benefits of protein supplements and guidance for consumers to identify safe and effective protein powder products.

New data from the longest known trial of pediatrics and adolescents in the postacute phase of COVID-19 show they are at a heightened risk of gastrointestinal tract symptoms.

Clinical decision support systems based on algorithms have improved outcomes and reduced costs in other health care settings.

Second-line and later treatment options for small cell lung cancer are limited.

Donna Ryan explains why long-term treatment with GLP-1 medication is typically necessary to maintain weight loss benefits.

Nivolumab demonstrated a sustained disease-free survival benefit over placebo in high-risk muscle-invasive urothelial carcinoma (MIUC).

The approval makes the vaccine the first of its kind for this indication in the United States.

The data were presented at the 2025 ASCO Genitourinary Cancers Symposium.

Pharmacists can support patients with treatment education, monitoring, and adherence, helping to overcome challenges posed by cognitive decline.

The authors are optimistic that these findings may help develop defenses to prevent food allergies in at-risk infants.